Immune responses associated with protection induced by chemoattenuated PfSPZ vaccine in malaria-naive Europeans
Open Access
- 2 April 2024
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (9)
Abstract
Vaccination of malaria-naive volunteers with a high dose of Plasmodium falciparum sporozoites chemoattenuated by chloroquine (CQ) (PfSPZ-CVac [CQ]) has previously demonstrated full protection against controlled human malaria infection (CHMI). However, lower doses of PfSPZ-CVac [CQ] resulted in incomplete protection. This provides the opportunity to understand the immune mechanisms needed for better vaccine-induced protection by comparing individuals who were protected with those not protected. Using mass cytometry, we characterized immune cell composition and responses of malaria-naive European volunteers who received either lower doses of PfSPZ-CVac [CQ], resulting in 50% protection irrespective of the dose, or a placebo vaccination, with everyone becoming infected following CHMI. Clusters of CD4 + and γδ T cells associated with protection were identified, consistent with their known role in malaria immunity. Additionally, EMRA CD8 + T cells and CD56 + CD8 + T cell clusters were associated with protection. In a cohort from a malaria-endemic area in Gabon, these CD8 + T cell clusters were also associated with parasitemia control in individuals with lifelong exposure to malaria. Upon stimulation with P . falciparum –infected erythrocytes, CD4 + , γδ, and EMRA CD8 + T cells produced IFN-γ and/or TNF, indicating their ability to mediate responses that eliminate malaria parasites.Keywords
Funding Information
- WISE (PSIA2020AGDG-3316)
- Norges Idrettshøgskole (5R44AI055229)
- Norges Idrettshøgskole (5R44AI058375)
- Norges Idrettshøgskole (U01A165745)
- EDCTP2 (RIA2018SV-2310)
- Deutsches Zentrum für Infektionsforschung (DZIF TTU 03.802)
This publication has 36 references indexed in Scilit:
- Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trialThe Lancet Infectious Diseases, 2022
- Origin and differentiation of human memory CD8 T cells after vaccinationNature, 2017
- Sterile protection against human malaria by chemoattenuated PfSPZ vaccineNature, 2017
- Protection against malaria at 1 year and immune correlates following PfSPZ vaccinationNature Medicine, 2016
- Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trialThe Lancet, 2015
- Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisationNature Communications, 2013
- A deep profiler's guide to cytometryTrends in Immunology, 2012
- Mass Cytometry: Technique for Real Time Single Cell Multitarget Immunoassay Based on Inductively Coupled Plasma Time-of-Flight Mass SpectrometryAnalytical Chemistry, 2009
- CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodesNature Medicine, 2007
- Expansion of unconventional T cells with natural killer markers in malaria patientsParasitology International, 2003